***Please complete this application and remove or replace all the blue, italic instructions.*** Project Title:Must be different from ongoing or pending research. Principal Investigator(s):
Name (primary contact person)
Organization
Address
Email
Phone Number
Name Co PI (if applicable)
Organization
Address
Email
Phone Number
Project Duration:XX Months
Amount Requested:
Direct:
Indirect (Max 8%):
TOTAL:
(Max $15,000)
Is this an application resubmission? Yes No
Lay Abstract:
Limit to 250 words - Statement of Research Problem and Objectives in lay language for public audiences
STUDY PROPOSAL
Scientific Abstract
Scientific summary of research in 250 words or less
Since CHF has restrictions on dogs used in research, please clearly indicate where the participating dogs and/or samples will be obtained. Specific treatment protocols for the animals should be included in the Experimental Methods and Design. CHF will not fund the purchase of dogs, support of dog research colonies, projects involving disease induction or injury models in dogs, or euthanasia of healthy dogs. 6. Expected Outcome, Significance, and Application of Findings
Limit 200 words 7. Anticipated Problems or Obstacles
List the Primary Investigator and Co-Investigators with their credentials and role descriptions. NIH Biographical Sketch (http://grants.nih.gov/grants/funding/phs398/biosketch.doc) format may be used and attached to the application.
REFERENCES
BUDGET ESTIMATES
Provide Cost Estimates based on the below categories. Please complete the table as applicable to your project.
Tenure status information must be provided for all Principal Investigators and Professorship titles requesting salary or they will be assumed to be tenure or tenure-tracked and not eligible for funding.
PROJECT TIMELINE
Project timeline that identifies intermediate project milestones with dates for specific objectives to be completed.
ONGOING/PENDING/PREVIOUS RESEARCH SUPPORT
Include any previous or current CHF funding including grant number and title.
Provide a brief description of other related ongoing or pending research support by project title, funding source and amount approved or requested.
If the manufacturer of the drug or technology may benefit financially from the results of the study, indicate their contribution to the study.